In vivo imaging in the second near-infrared window (NIR-II, 1000–1700 nm), which enables
us to look deeply into living subjects, is producing marvelous opportunities for biomedical …

Metal agents have made incredible strides in preclinical research and clinical applications in
recent years, but their short emission/absorption wavelengths continue to be a barrier to …

Malignant brain tumors, a heterogeneous group of primary and metastatic neoplasms in the
central nervous system (CNS), are notorious for their highly invasive and devastating …

Fluorescence imaging in the second near-infrared window (NIR-II) has become a prevalent
choice owing to its appealing advantages like deep penetration depth, low …

Fluorescence imaging in the second near‐infrared (NIR‐II) window holds great promise for
in vivo visualization of amyloid‐β (Aβ) pathology, which can facilitate characterization and …

The specific diagnosis and treatment of gliomas is a primary challenge in clinic due to their
high invasiveness and blood-brain barrier (BBB) obstruction. It is highly desirable to find a …

In vivo imaging technologies have emerged as a powerful tool for both fundamental
research and clinical practice. In particular, luminescence imaging in the tissue-transparent …

Brain tumors, especially glioblastoma, remain the most aggressive form of all the cancers
because of inefficient diagnosis and profiling. Nanostructures, such as metallic …

The development of supramolecular coordination complexes (SCCs) with a bright aggregate
state or mechanical-stimuli-responsive luminescence is very significant and challenging …

Fluorescence imaging with high sensitivity and minimal invasiveness has received
tremendous attention, which can accomplish visualized monitoring and evaluation of cancer …